omeprazole has been researched along with Dermatoses in 6 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omeprazole has been associated with multiple adverse effects including skin reactions but, to date, cutaneous hyperpigmentation has not been described as an adverse effect of this drug." | 7.73 | Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. ( Alcolea-Rubio, LA; Ibarra-Berrocal, IJ; Martínez-Barba, E; Martínez-Escribano, JA; Ramírez-Hernández, M, 2006) |
| "Omeprazole has been associated with multiple adverse effects including skin reactions but, to date, cutaneous hyperpigmentation has not been described as an adverse effect of this drug." | 3.73 | Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. ( Alcolea-Rubio, LA; Ibarra-Berrocal, IJ; Martínez-Barba, E; Martínez-Escribano, JA; Ramírez-Hernández, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, V | 1 |
| Kumarasinghe, SP | 1 |
| Kai, Y | 1 |
| Okamoto, O | 1 |
| Fujiwara, S | 1 |
| Ramírez-Hernández, M | 1 |
| Martínez-Escribano, JA | 1 |
| Martínez-Barba, E | 1 |
| Alcolea-Rubio, LA | 1 |
| Ibarra-Berrocal, IJ | 1 |
| Sakurane, M | 1 |
| Shiotani, A | 1 |
| Furukawa, F | 1 |
| Miwa, H | 1 |
| Kurosawa, A | 1 |
| Sato, N | 1 |
| Lee, ML | 1 |
| Piper, DW | 1 |
| Fischer, GO | 1 |
| De Launey, WE | 1 |
1 review available for omeprazole and Dermatoses
| Article | Year |
|---|---|
[Adverse effects of H. pylori eradication therapy and its measure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Diarrhea; Drug Therap | 2002 |
1 trial available for omeprazole and Dermatoses
| Article | Year |
|---|---|
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2002 |
4 other studies available for omeprazole and Dermatoses
| Article | Year |
|---|---|
Ashy dermatosis or ashy dermatosis-like pigmentation caused by omeprazole?
Topics: Erythema; Humans; Omeprazole; Pigmentation; Pigmentation Disorders; Skin Diseases | 2017 |
Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole.
Topics: Analgesics, Opioid; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Histamine | 2011 |
Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.
Topics: Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Female; Humans; Hyperpigmentation; Middle Aged; | 2006 |
Lichen spinulosus after the ingestion of omeprazole.
Topics: Adult; Female; Humans; Melena; Omeprazole; Skin Diseases | 1989 |